METHOTREXATE REDUCED TNF BIOACTIVITY BY ANTI-INFLIXIMAB ANTIBODY PREVENTION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB

被引：0
|
作者：
Denarie, D. [1 ]
Rinaudo, M. [2 ]
Thomas, T. [1 ]
Paul, S. [2 ]
Marotte, H. [1 ]
机构：
[1] Chu St Etienne France, Rheumatol Unit, St Etienne, France
[2] Chu St Etienne France, Immunol & Immunomonitoring Dept, St Etienne, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.3296
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0109
引用
收藏
页码：459 / 459
页数：1
相关论文
共 50 条
  • [31] Disseminated cryptococcal infection in rheumatoid arthritis treated with methotrexate and infliximab
    True, DG
    Penmetcha, M
    Peckham, SJ
    JOURNAL OF RHEUMATOLOGY, 2002, 29 (07) : 1561 - 1563
  • [32] Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody infliximab - A prospective study
    Lange, U
    Teichmann, J
    Strunk, J
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 443 - 444
  • [33] Infliximab and methotrexate in the treatment of rheumatoid arthritis
    Lipsky, PE
    van der Heijde, DMFM
    St Clair, EW
    Furst, DE
    Breedveld, FC
    Kalden, JR
    Smolen, JS
    Weisman, M
    Emery, P
    Feldmann, M
    Harriman, GR
    Maini, RN
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22): : 1594 - 1602
  • [34] Detectable Anti-Infliximab Antibodies in Children Treated with Infliximab for Rheumatic Diseases
    Aeschlimann, Florence A.
    Hofer, Kevin
    Schneider, Elvira Cannizzaro
    Schroeder, Silke
    Lauener, Roger
    van der Kleij, Desiree
    Rispens, Theo
    Saurenmann, R. K.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S7 - S7
  • [35] Reduction of oxidative stress marker levels by anti-TNF-α antibody, infliximab, in patients with rheumatoid arthritis
    Kageyama, Y.
    Takahashi, M.
    Ichikawa, T.
    Torikai, E.
    Nagano, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (01) : 73 - 80
  • [36] Effects of the anti-TNF-antibody infliximab on markers of bone turnover in patients with rheumatoid arthritis.
    Mueller, TJ
    Hermann, J
    Fahrleitner, A
    Yazdani-Biuki, B
    Dimai, HP
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S232 - S232
  • [37] An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status
    van der Bijl, Arie E.
    Breedveld, Ferdinand C.
    Antoni, Christian E.
    Kalden, Joachim R.
    Kary, Sonja
    Burmester, Gerd R.
    Beckmann, Christina
    Unnebrink, Kristina
    Kupper, Hartmut
    CLINICAL RHEUMATOLOGY, 2008, 27 (08) : 1021 - 1028
  • [38] Efficacy of adalimumab and methotrexate combination therapy on generalized pustular psoriasis patients unresponsive to infliximab monotherapy due to anti-infliximab antibody development
    Kawakami, Hiroshi
    Maeda, Tatsurou
    Abe, Namiko
    Matsumoto, Yuka
    Mitsuhashi, Yoshihiko
    Tsuboi, Ryoji
    Okubo, Yukari
    JOURNAL OF DERMATOLOGY, 2015, 42 (01): : 94 - 95
  • [39] Lipid profile in patients with rheumatoid arthritis treated with TNF alpha antagonist infliximab
    Kotyla, PJ
    Kucharz, EJ
    Lewicki, M
    Kotulska, AT
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 406 - 407
  • [40] Serum protein profile of rheumatoid arthritis treated with anti-TNF therapy (infliximab)
    Takeuchi, Tohru
    Nakanishi, Toyofumi
    Tabushi, Yoko
    Hata, Ayu
    Shoda, Takeshi
    Kotani, Takuya
    Shimizu, Akira
    Takubo, Takayuki
    Makino, Shigeki
    Hanafusa, Toshiaki
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 855 (01): : 66 - 70
12345